"Step-By-Step Approach Followed": Bharat Biotech On Brazil Covaxin Deal Row

Wednesday, 30 June 2021Newsdesk

Bharat Biotech said today that it had followed a "step-by-step" approach towards contracts and regulatory approvals with Brazil amid investigations in the country to the deal for 20 million Covaxin doses. Brazil has decided to suspend a $ 324 million contract, which has engulfed President Jair Bolsonaro in accusations of irregularities, on the advice of the federal comptroller.

New Delhi, 30 June 2021

As per news report of NDTV,"In the specific case of procurement of Covaxin by the Ministry of Health, Brazil, since the first meetings during Nov 2020 until June 29, a step-by-step approach has been followed towards contracts, and regulatory approvals, during this eight-month-long process," Bharat Biotech said in a statement. "EUA received on June 4. As of June 29, Bharat Biotech has not received any advance payments nor supplied any vaccines to MOH Brazil. Bharat Biotech has followed a similar approach towards contracts, regulatory approvals and supplies in several countries worldwide, where Covaxin is being supplied successfully," said the Hyderabad-based vaccine maker.

Source -NDTV